Format

Send to

Choose Destination
Adv Drug Deliv Rev. 2017 Nov 1;121:147-157. doi: 10.1016/j.addr.2017.05.018. Epub 2017 May 31.

Engineering in vitro models of hepatofibrogenesis.

Author information

1
University College London (UCL), Regenerative Medicine & Fibrosis Group, Institute for Liver & Digestive Health, Royal Free Hospital, London, United Kingdom. Electronic address: giuseppe.mazza.12@ucl.ac.uk.
2
University College London (UCL), Regenerative Medicine & Fibrosis Group, Institute for Liver & Digestive Health, Royal Free Hospital, London, United Kingdom.
3
University College London (UCL), Regenerative Medicine & Fibrosis Group, Institute for Liver & Digestive Health, Royal Free Hospital, London, United Kingdom. Electronic address: k.rombouts@ucl.ac.uk.

Abstract

Chronic liver disease is a major cause of morbidity and mortality worldwide marked by chronic inflammation and fibrosis/scarring, resulting in end-stage liver disease and its complications. Hepatic stellate cells (HSCs) are a dominant contributor to liver fibrosis by producing excessive extracellular matrix (ECM), irrespective of the underlying disease aetiologies, and for many decades research has focused on the development of a number of anti-fibrotic strategies targeting this cell. Despite major improvements in two-dimensional systems (2D) by using a variety of cell culture models of different complexity, an efficient anti-fibrogenic therapy has yet to be developed. The development of well-defined three-dimensional (3D) in vitro models, which mimic ECM structures as found in vivo, have demonstrated the importance of cell-matrix bio-mechanics, the complex interactions between HSCs and hepatocytes and other non-parenchymal cells, and this to improve and promote liver cell-specific functions. Henceforth, refinement of these 3D in vitro models, which reproduce the liver microenvironment, will lead to new objectives and to a possible new era in the search for antifibrogenic compounds.

KEYWORDS:

2 dimensional system (2D); 3 dimensional system (3D); Cell sheet stacking; Decellularised liver scaffolds; Extracellular matrix (ECM); Hepatic stellate cells (HSCs); Liver fibrosis; Matrigel/hydrogel; Organoids/spheroids; Precision-Cut Liver Slices (PCLS)

PMID:
28578016
DOI:
10.1016/j.addr.2017.05.018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center